Search the NeLM

Medicines A-Z
Find key information about medicines by name (prototype)
NIH program helps developers navigate path to new drugs for neglected diseases

Original article by: R Voelcker

Reference: Journal of the American Medical Association 8 Feb 2012;307(6):549-550

Source: Journal of the American Medical Association

Keywords: Drug Development; Drugs-Investigational; Government; United States;

Date published: 08/02/2012 08:08

Summary
by: Pharm-line

News feature on the Therapeutics for Rare and Neglected Diseases (TRND) programme of the US National Institutes of Health (NIH).  Since 2009, the programme has solicited proposals from scientists and pharmaceutical companies aiming to get promising compounds for treatment of rare and neglected diseases into human clinical trials.  So far, the TRND has received 125 applications for non-monetary assistance, of which 10 have been approved.

About this library entry
Category: Government / regulatory | Pharmaceutical Industry
NeLM area:  Evidence > Medicines Management > References
Extract link

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.
Back